Labeling and exocytosis of secretory compartments in RBL mastocytes by polystyrene and mesoporous silica nanoparticles

BACKGROUND: For a safe ‘in vivo’ biomedical utilization of nanoparticles, it is essential to assess not only biocompatibility, but also the potential to trigger unwanted side effects at both cellular and tissue levels. Mastocytes (cells having secretory granules containing cytokines, vasoactive amin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekkapongpisit, Maneerat, Giovia, Antonino, Nicotra, Giuseppina, Ozzano, Matteo, Caputo, Giuseppe, Isidoro, Ciro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352688/
https://www.ncbi.nlm.nih.gov/pubmed/22605932
http://dx.doi.org/10.2147/IJN.S29034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352688/
https://www.ncbi.nlm.nih.gov/pubmed/22605932
http://dx.doi.org/10.2147/IJN.S29034

Ejemplares similares